PMID: 9160569Jan 1, 1994Paper

Pharmacotherapy of post-traumatic stress disorder with a novel psychotropic

Anxiety
R J KatzR McIvor

Abstract

This was a multicenter, randomized, double-blind, parallel trial conducted in outpatients in three countries. Following screening and placebo washout, patients received brofaromine (a combined MAO-A inhibitor/5-HT transport inhibitor) or placebo in a flexible dosing design. Based upon the CAPS, a standardized post-traumatic stress disorder (PTSD) interview, findings from a cohort involving both subchronic and chronic traumatic stress marginally favored brofaromine over placebo; however, not to a statistically significant degree. With a more conservation definition of the syndrome, employing a primary cohort of patients with PTSD of one year or greater duration, brofaromine significantly reduced PTSD symptoms in comparison with placebo. In all analyses a substantial proportion of patients in both drug and placebo groups remained symptomatic throughout. Findings were supported by an analysis of secondary measures. Brofaromine may be of benefit in the therapy of PTSD.

References

Aug 5, 1992·JAMA : the Journal of the American Medical Association·S D SolomonA M Muff
May 1, 1991·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·A Delcker, H J Gaertner
Aug 1, 1991·Journal of Abnormal Psychology·J R Davidson, E B Foa
Mar 1, 1990·Archives of General Psychiatry·J DavidsonJ O Cavenar
Apr 1, 1989·The American Journal of Psychiatry·C ReistJ N Nelson
Oct 1, 1988·The American Journal of Psychiatry·J B FrankE Dan
May 1, 1988·Psychiatry Research·M ShestatzkyB Lerer

❮ Previous
Next ❯

Citations

Apr 17, 2001·Depression and Anxiety·D L Dunner
Jun 5, 2001·Depression and Anxiety·F W WeathersJ R Davidson
Jul 27, 2001·Current Psychiatry Reports·S Seedat, M B Stein
Nov 21, 2002·Current Psychiatry Reports·Marian I ButterfieldChristine E Marx
Oct 24, 2002·Journal of Psychiatric Research·Ronald C Albucher, Israel Liberzon
Feb 13, 2001·Pharmacology, Biochemistry, and Behavior·L A LumleyJ L Meyerhoff
May 5, 2001·Pharmacology & Therapeutics·S V ArgyropoulosD J Nutt
Apr 11, 2001·Progress in Neuro-psychopharmacology & Biological Psychiatry·K M ConnorJ R Davidson
Aug 25, 2007·Annual Review of Clinical Psychology·Terence M KeaneCasey T Taft
Dec 18, 2004·Forschende Komplementärmedizin und klassische Naturheilkunde = Research in complementary and natural classical medicine·L Sher
Aug 22, 2008·Croatian Medical Journal·Dragica Kozaric-Kovacic
Apr 7, 2007·Journal of Clinical Psychopharmacology·Ferenc MartenyiCatherine D Caldwell
May 21, 2009·Expert Opinion on Emerging Drugs·Dewleen G BakerVictoria B Risbrough
Feb 9, 2016·Progress in Neuro-psychopharmacology & Biological Psychiatry·Ralph J KoekAndrew Leuchter
Oct 2, 2009·Journal of Psychiatric Research·Alessandra A LimaIvan Figueira
Jun 1, 2009·Psychiatric Annals·Gregory M Sullivan, Yuval Neria
Dec 17, 2005·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Ferenc Martenyi, Victoria Soldatenkova
Oct 22, 2002·Expert Opinion on Pharmacotherapy·Ann C Schwartz, Barbara O Rothbaum
Apr 5, 2014·European Journal of Pharmacology·Hendrikus HendriksenRonald S Oosting
Jul 30, 2011·The International Journal of Neuropsychopharmacology·Jonathan C Ipser, Dan J Stein
Aug 17, 2000·Depression and Anxiety·R M Hirschfeld
Feb 16, 2008·The Journal of Nervous and Mental Disease·John A StuartSimon Wessely
Feb 24, 1998·Journal of Clinical Psychopharmacology·J R DavidsonL A Tupler
Mar 13, 2003·Perspectives in Psychiatric Care·Maryhelen C KreidlerRhonda R Beech
Jan 27, 2006·The Cochrane Database of Systematic Reviews·D J SteinS Seedat
Jan 10, 2002·Acta Psychiatrica Scandinavica·I HagemanM B Jørgensen
Jun 21, 1997·Annals of the New York Academy of Sciences·M J Friedman
Feb 10, 2004·CNS Spectrums·Dan J SteinUNKNOWN World Council of Anxiety
Aug 5, 2000·The Annals of Pharmacotherapy·M Cyr, M K Farrar

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anxiety Disorders

Discover the latest research on anxiety disorders including agoraphobia, panic disorder, obsessive-compulsive disorder, and post-traumatic stress disorder here.